Stay updated on EB01 Cream in Chronic Allergic Contact Dermatitis Clinical Trial

Sign up to get notified when there's something new on the EB01 Cream in Chronic Allergic Contact Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EB01 Cream in Chronic Allergic Contact Dermatitis Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The core study details, eligibility criteria, and outcomes appear unchanged; the differences visible are limited to minor formatting/layout differences. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T02:42:47.000Z thumbnail image
  3. Check
    32 days ago
    Change Detected
    Summary
    Summary of changes: added a government-operating-status notice and explicit open status for NIH Clinical Center with links to official sources, and updated version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T15:55:03.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T09:50:11.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Minor version update from v3.0.1 to v3.0.2. The removal of the 'Back to Top' link is a small UI change and does not affect core content, pricing, stock, or time-sensitive information.
    Difference
    0.2%
    Check dated 2025-09-14T23:44:45.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T20:25:13.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically clarifying the address to Washington D.C., District of Columbia, United States, 20016, and has added a focus on Skin and Connective Tissue Diseases.
    Difference
    2%
    Check dated 2025-08-31T12:51:02.000Z thumbnail image

Stay in the know with updates to EB01 Cream in Chronic Allergic Contact Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EB01 Cream in Chronic Allergic Contact Dermatitis Clinical Trial page.